Self-reported medication and herb/supplement use by women with and without fibromyalgia

Joan L. Shaver, Joellen Wilbur, Hyeongkyeong Lee, F. Patrick Robinson, Edward Wang

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Methods: Using a telephone survey of 434 women who self-reported having and 198 women, who denied having fibromyalgia (FM) (aged 18-80 years), we compared women on self-reported number, major types, and effectiveness of currently taken conventional medications and herbs/supplements. Results: Ninety-three percent of women with FM reported taking at least one medication (1855 total, 499 types, on average 4.6per person) compared with 56% of women without FM (269 total, 172 types, 1.4per person on average). Half (n=217) of the women with FM reported taking antidepressant drugs; more reported selective serotonin reuptake inhibitors (SSRI)-type with moderate effectiveness than tricyclic amines deemed to have strong effectiveness. Few were taking dual uptake inhibitors or the now approved pregabalin. Nearly 30% reported taking nonsteroidal anti-inflammatory drugs (NSAID), which have weak efficacy evidence. Less than 8% of controls reported taking either antidepressants or NSAID. Having FM was associated with these medications plus guaifenesen, anticonvulsants, muscle relaxants, narcotics, other analgesics, and benzodiazepines. Highest effectiveness scores were for opioid narcotics and guaifenesin. Forty-three percent of women with FM reported taking at least one herb/supplement compared with 23% of control women. The most common types were omega esterified fatty acids, glucosamine, and gingko. No particular type distinguished between the groups. Both groups tended to rate overall effectiveness lower for herbs/supplements than for conventional medications. Conclusions: Substantial numbers of women with FM were taking pain medications that often lacked evidence for effectiveness. The variety of medications being taken by women with FM compared with women without FM indicates that there are few medications that consistently provide symptom alleviation for this condition.

Original languageEnglish
Pages (from-to)709-716
Number of pages8
JournalJournal of Women's Health
Volume18
Issue number5
DOIs
Publication statusPublished - 2009 May 1

Fingerprint

Fibromyalgia
Narcotics
Antidepressive Agents
Guaifenesin
Anti-Inflammatory Agents
Ginkgo biloba
Glucosamine
Serotonin Uptake Inhibitors
Benzodiazepines
Telephone
Pharmaceutical Preparations
Anticonvulsants
Opioid Analgesics
Amines
Fatty Acids

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Shaver, Joan L. ; Wilbur, Joellen ; Lee, Hyeongkyeong ; Robinson, F. Patrick ; Wang, Edward. / Self-reported medication and herb/supplement use by women with and without fibromyalgia. In: Journal of Women's Health. 2009 ; Vol. 18, No. 5. pp. 709-716.
@article{4e6428fac0544132b112414b92aa1c07,
title = "Self-reported medication and herb/supplement use by women with and without fibromyalgia",
abstract = "Methods: Using a telephone survey of 434 women who self-reported having and 198 women, who denied having fibromyalgia (FM) (aged 18-80 years), we compared women on self-reported number, major types, and effectiveness of currently taken conventional medications and herbs/supplements. Results: Ninety-three percent of women with FM reported taking at least one medication (1855 total, 499 types, on average 4.6per person) compared with 56{\%} of women without FM (269 total, 172 types, 1.4per person on average). Half (n=217) of the women with FM reported taking antidepressant drugs; more reported selective serotonin reuptake inhibitors (SSRI)-type with moderate effectiveness than tricyclic amines deemed to have strong effectiveness. Few were taking dual uptake inhibitors or the now approved pregabalin. Nearly 30{\%} reported taking nonsteroidal anti-inflammatory drugs (NSAID), which have weak efficacy evidence. Less than 8{\%} of controls reported taking either antidepressants or NSAID. Having FM was associated with these medications plus guaifenesen, anticonvulsants, muscle relaxants, narcotics, other analgesics, and benzodiazepines. Highest effectiveness scores were for opioid narcotics and guaifenesin. Forty-three percent of women with FM reported taking at least one herb/supplement compared with 23{\%} of control women. The most common types were omega esterified fatty acids, glucosamine, and gingko. No particular type distinguished between the groups. Both groups tended to rate overall effectiveness lower for herbs/supplements than for conventional medications. Conclusions: Substantial numbers of women with FM were taking pain medications that often lacked evidence for effectiveness. The variety of medications being taken by women with FM compared with women without FM indicates that there are few medications that consistently provide symptom alleviation for this condition.",
author = "Shaver, {Joan L.} and Joellen Wilbur and Hyeongkyeong Lee and Robinson, {F. Patrick} and Edward Wang",
year = "2009",
month = "5",
day = "1",
doi = "10.1089/jwh.2008.1194",
language = "English",
volume = "18",
pages = "709--716",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

Self-reported medication and herb/supplement use by women with and without fibromyalgia. / Shaver, Joan L.; Wilbur, Joellen; Lee, Hyeongkyeong; Robinson, F. Patrick; Wang, Edward.

In: Journal of Women's Health, Vol. 18, No. 5, 01.05.2009, p. 709-716.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Self-reported medication and herb/supplement use by women with and without fibromyalgia

AU - Shaver, Joan L.

AU - Wilbur, Joellen

AU - Lee, Hyeongkyeong

AU - Robinson, F. Patrick

AU - Wang, Edward

PY - 2009/5/1

Y1 - 2009/5/1

N2 - Methods: Using a telephone survey of 434 women who self-reported having and 198 women, who denied having fibromyalgia (FM) (aged 18-80 years), we compared women on self-reported number, major types, and effectiveness of currently taken conventional medications and herbs/supplements. Results: Ninety-three percent of women with FM reported taking at least one medication (1855 total, 499 types, on average 4.6per person) compared with 56% of women without FM (269 total, 172 types, 1.4per person on average). Half (n=217) of the women with FM reported taking antidepressant drugs; more reported selective serotonin reuptake inhibitors (SSRI)-type with moderate effectiveness than tricyclic amines deemed to have strong effectiveness. Few were taking dual uptake inhibitors or the now approved pregabalin. Nearly 30% reported taking nonsteroidal anti-inflammatory drugs (NSAID), which have weak efficacy evidence. Less than 8% of controls reported taking either antidepressants or NSAID. Having FM was associated with these medications plus guaifenesen, anticonvulsants, muscle relaxants, narcotics, other analgesics, and benzodiazepines. Highest effectiveness scores were for opioid narcotics and guaifenesin. Forty-three percent of women with FM reported taking at least one herb/supplement compared with 23% of control women. The most common types were omega esterified fatty acids, glucosamine, and gingko. No particular type distinguished between the groups. Both groups tended to rate overall effectiveness lower for herbs/supplements than for conventional medications. Conclusions: Substantial numbers of women with FM were taking pain medications that often lacked evidence for effectiveness. The variety of medications being taken by women with FM compared with women without FM indicates that there are few medications that consistently provide symptom alleviation for this condition.

AB - Methods: Using a telephone survey of 434 women who self-reported having and 198 women, who denied having fibromyalgia (FM) (aged 18-80 years), we compared women on self-reported number, major types, and effectiveness of currently taken conventional medications and herbs/supplements. Results: Ninety-three percent of women with FM reported taking at least one medication (1855 total, 499 types, on average 4.6per person) compared with 56% of women without FM (269 total, 172 types, 1.4per person on average). Half (n=217) of the women with FM reported taking antidepressant drugs; more reported selective serotonin reuptake inhibitors (SSRI)-type with moderate effectiveness than tricyclic amines deemed to have strong effectiveness. Few were taking dual uptake inhibitors or the now approved pregabalin. Nearly 30% reported taking nonsteroidal anti-inflammatory drugs (NSAID), which have weak efficacy evidence. Less than 8% of controls reported taking either antidepressants or NSAID. Having FM was associated with these medications plus guaifenesen, anticonvulsants, muscle relaxants, narcotics, other analgesics, and benzodiazepines. Highest effectiveness scores were for opioid narcotics and guaifenesin. Forty-three percent of women with FM reported taking at least one herb/supplement compared with 23% of control women. The most common types were omega esterified fatty acids, glucosamine, and gingko. No particular type distinguished between the groups. Both groups tended to rate overall effectiveness lower for herbs/supplements than for conventional medications. Conclusions: Substantial numbers of women with FM were taking pain medications that often lacked evidence for effectiveness. The variety of medications being taken by women with FM compared with women without FM indicates that there are few medications that consistently provide symptom alleviation for this condition.

UR - http://www.scopus.com/inward/record.url?scp=68349156007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349156007&partnerID=8YFLogxK

U2 - 10.1089/jwh.2008.1194

DO - 10.1089/jwh.2008.1194

M3 - Article

C2 - 19445618

AN - SCOPUS:68349156007

VL - 18

SP - 709

EP - 716

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 5

ER -